Latest in Eli Lilly’s
Sort by
9 items
-
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.CNBC - 1d -
Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.CNBC - 1d -
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.CNBC - 5d -
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.MarketWatch - 5d -
Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise
Eli Lilly has been one of the worst-performing Club stocks over the past six months.CNBC - 6d -
Eli Manning says 'only one team' he'd take an ownership stake in: The New York Giants
Former New York Giants quarterback Eli Manning would consider becoming a minority owner of his old team if the Mara family is willing to sell him a stake.NBC News - Jan. 6 -
Eli Manning says 'only one team' he'd take an ownership stake in: The New York Giants
Former New York Giants quarterback Eli Manning told CNBC he's interested in becoming a minority owner of his former team, if the Mara family is willing to sell.CNBC - Jan. 6 -
Eli Health introduces Hormometer to test your hormones on a smartphone
This is how smart your smartphone is getting. Now it will be able to analyze your saliva and do a real-time hormone test.VentureBeat - Jan. 6